ArticleESMO gastrointestinal oncology2026
Impact of nutritional risk screening on outcomes of first-line treatment in metastatic esophagogastric adenocarcinoma: a secondary analysis of the AIO-MATEO trial.
R Stelmach et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.